Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roche Holding AG (RHHBY)
:RHHBY
Holding RHHBY?
Track your performance easily
RHHBY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$29.20 - $42.43
Previous CloseN/A
Volume3.10M
Average Volume (3M)1.37M
Market Cap
$233.41B
Enterprise Value$255.34B
Total Cash (Recent Filing)$9.11B
Total Debt (Recent Filing)$16.99B
Price to Earnings (P/E)19.5
Beta0.23
Next Earnings
Jan 30, 2025EPS Estimate
1.21Last Dividend Ex-Date
Mar 14, 2024Dividend Yield2.34%
Share Statistics
EPS (TTM)1.88
Shares Outstanding5,620,501,500
10 Day Avg. Volume1,862,234
30 Day Avg. Volume1,372,411
Standard Deviation0.05
R-Squared0.17
Alpha-0.00401
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.21
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue2.56
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$41.67Price Target Upside14.16% Upside
Rating ConsensusHold
Number of Analyst Covering4
Roche Holding News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.70% Mutual Funds
<0.01% Other Institutional Investors
99.25% Public Companies and Individual Investors
RHHBY FAQ
What was Roche Holding AG’s price range in the past 12 months?
Roche Holding AG lowest stock price was $29.20 and its highest was $42.43 in the past 12 months.
What is Roche Holding AG’s market cap?
Roche Holding AG’s market cap is $233.41B.
When is Roche Holding AG’s upcoming earnings report date?
Roche Holding AG’s upcoming earnings report date is Jan 30, 2025 which is in 12 days.
How were Roche Holding AG’s earnings last quarter?
Roche Holding AG released its earnings results on Jul 25, 2024. The company reported $1.433 earnings per share for the quarter, beating the consensus estimate of $1.305 by $0.128.
Is Roche Holding AG overvalued?
According to Wall Street analysts Roche Holding AG’s price is currently Undervalued.
Does Roche Holding AG pay dividends?
Roche Holding AG pays a Annually dividend of $0.875 which represents an annual dividend yield of 2.34%. See more information on Roche Holding AG dividends here
What is Roche Holding AG’s EPS estimate?
Roche Holding AG’s EPS estimate is 1.21.
How many shares outstanding does Roche Holding AG have?
Roche Holding AG has 5,620,501,500 shares outstanding.
What happened to Roche Holding AG’s price movement after its last earnings report?
Roche Holding AG reported an EPS of $1.433 in its last earnings report, beating expectations of $1.305. Following the earnings report the stock price went up 2.647%.
Which hedge fund is a major shareholder of Roche Holding AG?
Currently, no hedge funds are holding shares in RHHBY
---
Roche Holding Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$41.67 (14.16% Upside)
$41.67 (14.16% Upside)
Blogger Sentiment
Bullish
RHHBY Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 11.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.67%
12-Months-Change
Fundamentals
Return on Equity
38.68%
Trailing 12-Months
Asset Growth
13.03%
Trailing 12-Months
Company Description
Roche Holding AG
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
---
RHHBY Company Deck
---
RHHBY Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in core operating profit, strong performance in the Pharma and Diagnostics divisions, and multiple regulatory achievements. However, there were challenges in the Japanese market, discontinuation of key studies, and impacts from COVID-19 and loss of exclusivity.Read More>---
RHHBY Stock 12 Month Forecast
Average Price Target
$41.67
▲(14.16% Upside)
Technical Analysis
Novartis
―
Merck & Company
―
GlaxoSmithKline
―
AstraZeneca
―
Eli Lilly & Co
―
Bristol-Myers Squibb
―
Best Analysts Covering RHHBY
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-5.80%
initiated a sell rating 12 months ago
Copying Mark Purcell's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -5.80% per trade.
---